Unique ID issued by UMIN | UMIN000058836 |
---|---|
Receipt number | R000067278 |
Scientific Title | Effects of wearing a test substance that generates far-infrared rays and weak electric currents on concentration and physical range of motion: a randomized, double blind, placebo-controlled study |
Date of disclosure of the study information | 2025/08/20 |
Last modified on | 2025/08/19 13:27:55 |
Effects of wearing a test substance that generates far-infrared rays and weak electric currents on concentration and physical range of motion.
RES study
Effects of wearing a test substance that generates far-infrared rays and weak electric currents on concentration and physical range of motion: a randomized, double blind, placebo-controlled study
Effects of wearing a test substance that generates far-infrared rays and weak electric currents on concentration and physical range of motion.
Japan |
Healthy adult
Adult |
Others
NO
Evaluating the effects of wearing test products on concentration and physical range of motion
Efficacy
Concentration Assessment Test, measurement of physical range of motion
subjective evaluation
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Treatment
Device,equipment |
For concentration assessment, the hat-type device (test product) was worn once, and for range of motion assessment, the ankle band-type device (test product) was worn for two weeks.
For concentration assessment, the hat-type device (placebo) was worn once, and for range of motion assessment, the ankle band-type device (placebo) was worn for two weeks.
20 | years-old | <= |
65 | years-old | >= |
Male and Female
1.Subjects who suffer from fatigue, stiff shoulders, or lower back pain
2.Subjects who feel a decline in concentration or find it difficult to focus
1. Subjects with a history of treatment that may have affected the test site.
2. Subjects with color vision deficiency (reduced color perception).
3. Subjects unable to wash the test product.
4. Subjects who have started taking a new medication within the past two months.
5. Subjects currently attending chiropractic clinics, gyms, or yoga classes.
6. Subjects planning to change their lifestyle during the study period.
7. Subjects who have participated in or plan to participate in other clinical trials within the past month prior to consent acquisition.
8. Subjects who are currently pregnant or breastfeeding (including those who have recently given birth).
9. Subjects with alcoholism or heavy smokers.
10. Subjects with a history of food or contact allergies.
11. Subjects receiving hormone replacement therapy.
12. Subjects unable to walk independently without assistance.
13. Subjects suspected of mild or severe dementia.
14. Subjects deemed inappropriate by the principal investigator.
24
1st name | Takeshi |
Middle name | |
Last name | Kaneko |
Japan Clinical Trial Association
N.A.
1600022
5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo
0364574666
info@yakujihou.org
1st name | Takeshi |
Middle name | |
Last name | Kaneko |
Japan Clinical Trial Association
N.A.
1600022
5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo
0364574666
info@yakujihou.org
Japan Clinical Trial Association
Relive Co.,Ltd.
Profit organization
Institutional Review Board of Pharmaceutical Law Wisdoms
5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo
0364574911
master@yakujihou.net
NO
2025 | Year | 08 | Month | 20 | Day |
Unpublished
Preinitiation
2025 | Year | 07 | Month | 01 | Day |
2025 | Year | 07 | Month | 10 | Day |
2025 | Year | 08 | Month | 20 | Day |
2025 | Year | 09 | Month | 10 | Day |
2025 | Year | 08 | Month | 19 | Day |
2025 | Year | 08 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067278